93 related articles for article (PubMed ID: 6635442)
1. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus.
Van der Auwera P; Klastersky J
Rev Infect Dis; 1983; 5 Suppl 3():S509-14. PubMed ID: 6635442
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
Maduri Traczewski M; Goldmann DA; Murphy P
Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
Johnston BL; Kwok RY; Mulligan ME
Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
Ho JL; Klempner MS
Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
[TBL] [Abstract][Full Text] [Related]
5. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
[TBL] [Abstract][Full Text] [Related]
6. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
Lorian V; Atkinson B; Kim Y
Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
[TBL] [Abstract][Full Text] [Related]
7. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
8. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
[TBL] [Abstract][Full Text] [Related]
9. Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.
Croes S; Beisser PS; Neef C; Bruggeman CA; Stobberingh EE
Antimicrob Agents Chemother; 2010 Sep; 54(9):3907-12. PubMed ID: 20606067
[TBL] [Abstract][Full Text] [Related]
10. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
Iluz N; Maor Y; Keller N; Malik Z
Lasers Surg Med; 2018 Jul; 50(5):535-551. PubMed ID: 29333608
[TBL] [Abstract][Full Text] [Related]
13. Antistaphylococcal activity of rifampin with other antibiotics.
Zinner SH; Lagast H; Klastersky J
J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
[TBL] [Abstract][Full Text] [Related]
14. Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus.
Ruane PJ; Morgan MA; Citron DM; Mulligan ME
J Clin Microbiol; 1986 Sep; 24(3):490-2. PubMed ID: 3489732
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Antistaphylococcal Synergistic Effect of Isoflavone Metabolite Demethyltexasin with Amoxicillin and Oxacillin.
Rondevaldova J; Hummelova J; Tauchen J; Kokoska L
Microb Drug Resist; 2018; 24(1):24-29. PubMed ID: 28570834
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
Baiocchi P; Galiè M; Santini C; Carfagna P; Cassone M; Tarasi D; Venditti M
J Chemother; 1998 Feb; 10(1):25-8. PubMed ID: 9531072
[TBL] [Abstract][Full Text] [Related]
17. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.
Komatsuzawa H; Suzuki J; Sugai M; Miyake Y; Suginaka H
J Antimicrob Chemother; 1994 Jun; 33(6):1155-63. PubMed ID: 7928809
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the in vitro antistaphylococcal effect of oxacillin and tetracycline by the anti-inflammatory drug diacetyl rhein.
Nguon S; Novy P; Kokoska L
Chemotherapy; 2013; 59(6):447-52. PubMed ID: 25138175
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
Kim YS; Kiem S; Yun HJ; Jung SI; Oh WS; Kim SW; Peck KR; Lee NY; Song JH
J Korean Med Sci; 2003 Jun; 18(3):319-24. PubMed ID: 12808315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
